Key Drivers
- Profit rebound
- Stronger liquidity
- High leverage
AIAI Summary
Centene has shifted from a distressed turnaround to a “prove-it” recovery story after delivering better margins, cash flow, and a raised 2026 outlook, but with the stock already rerated, the next leg higher depends on sustaining profitability without renewed medical-cost or membership pressure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profit rebound
- •Stronger liquidity
- •High leverage
Centene's latest quarter shows clear recovery in profitability, cash generation, and leverage, but the full-year loss and still-modest margins indicate a mixed, execution-dependent investment case.
Price Behavior
Key Price Behavior Insights:
- •Recovery rebound
- •Choppy range
- •Breakout pending
Over the last month, CNC has bounced from a late-July selloff into a choppy mid-60s recovery, but it still needs a sustained move above $68.7 to confirm a breakout.
Late-July selloff followed by a rebound into the mid-60s suggests short-term volatility but improving momentum
Sentiment & News
Key News Insights:
- •Q2 Beat
- •Outlook Raised
- •Mixed Membership
Centene posted a strong Q2 with earnings and revenue beats, a raised 2026 outlook, and improving profitability, though membership softness and elevated medical costs keep the story mixed.
The latest results are supportive for CNC's near-term trajectory, but continued cost and enrollment pressure could limit upside versus larger managed-care peers
Similar Companies in Healthcare
Other companies in the same sector with AI ratings